Search

Search Constraints

You searched for: Author/Creator Liu, Lawrence

Search Results

1. A single center retrospective study of daratumumab, pomalidomide, and dexamethasone as 2nd-line therapy in multiple myeloma. Issue 12 (15th October 2021)

2. Costs of telaprevir‐based triple therapy for hepatitis C: $189, 000 per sustained virological response. Issue 4 (25th August 2014)